Reduce the spread of germs on high touch points with antibacterial wipes and keep everyone safe.
Our antibacterial wipes are designed to clean and disinfectant most surfaces in an easy-to-use application. Antibacterial Wipes are engineered to reduce bacterial growth across a range of workplace settings and environments using a gentle and effective formula that cleans, sanitises and kills 99.9% of germs. A convenient way to clean and disinfect surfaces, our range of antibacterial wipes are an important tool in infection prevention and hygiene practices.
Our best-selling antibacterial wipes are available to purchase directly from our website in convenient multipacks and bundles.
Antibacterial wipes provide a convenient way to successfully remove bacteria from surfaces. Our antibacterial wipes are made from a durable, apertured fabric soaked in an antibacterial solution. Upon surface application, the solution is activated and kills a broad range of bacteria and viruses. For best results, it is recommended that you apply antibacterial wipes directly on clean surfaces, where soil has already been removed, to achieve the most efficient cleaning. It is also important to not use the same wipe over multiple surfaces, as you can transmit the bacteria or viruses across the spaces, we recommend one wipe in one direction. It is also important after use to reseal the packet to ensure that wipes do not dry out partially or completely to prevent wipes drying out which makes the wipe less effective at killing germs.
There are 3 simple steps you can take to reduce the spread of pathogens
Step 1 – Effective Surface Cleaning & Disinfection
Regular, effective surface cleaning, with hospital grade disinfectants will assist in protecting staff and patients.
Step 2 – Good Hand Hygiene
Ensuring quality hand sanitisers are easily accessible in waiting rooms and practice rooms will assist in minimising the risk of infection transmission.
Step 3 – Infection Prevention Education & Training
Whiteley provides education and training materials to ensure that healthcare workers and staff are up to date on the latest science, procedures and techniques to keep your facility clean and safe.
Answer: Antibacterial wipes are pre-moistened disposable wipes that are designed to kill bacteria and other germs on surfaces. They usually contain active ingredients such as alcohol or quaternary ammonium compounds that help to disinfect surfaces. Antibacterial wipes are commonly used to clean and disinfect surfaces in homes, hospitals, and other public spaces.
Answer: While antibacterial wipes are effective against bacteria, they may not be effective against all viruses. It’s important to check the label to ensure the product is effective against the specific viruses you are concerned about.
Answer: Antibacterial wipes are not designed for use on the skin and may cause skin irritation. It’s important to use products specifically designed for use on the skin, such as hand sanitisers.
Answer: Yes, it’s important to wear gloves when using antibacterial wipes, as they may contain chemicals that can be harmful to the skin. Additionally, it’s important to avoid contact with eyes and to keep the wipes out of reach of children and pets.
Answer: You can purchase antibacterial wipes at most supermarkets, pharmacies, and online retailers in Australia. In particular, Whiteley sells their antibacterial wipes on their website, and there are other brands available at various retailers. It’s important to check the product label and make sure the wipes are registered with the Australian Pesticides and Veterinary Medicines Authority (APVMA) to ensure their safety and effectiveness.
Whiteley offers advice, training and practical support for all of your infection prevention, medical device reprocessing, and professional cleaning needs.
You can view our product safety data sheets, technical bulletins and find out about the products from our range.
Speaker: Doctor Arthika Manoharan
Qualifications: Postdoctoral Research Fellow at University of Sydney
Speaker Profile:
Arthika is a Postdoctoral Research Fellow at The University of Sydney Infectious Diseases Institute, having recently completed her PhD in collaboration with Whiteley Corporation, under the supervision of Dr. Theerthankar Das and A/Prof Jim Manos. Her research aims to tackle biofilm formation in recurrent and catheter associated urinary tract infections, using antioxidants to circumvent antibiotic resistance and decipher how these antioxidants influence host-pathogen interactions in the bladder. A microbiologist with extensive immunology experience, Arthika has worked in various projects ranging from studying CAR T cells to antibiotic resistant biofilms. With 6 publications under her belt, Arthika is an enthusiastic early career researcher interested in multidisciplinary research that combines fundamental and translational sciences. She is also an avid advocate for EMCRs in the medical sciences, having served extensively on various EMCR committees university wide and in professional bodies, including ASM.
Topic: Rethinking biofilm treatments in catheter associated urinary tract infections
Presentation Outline: Catheter-associated urinary tract infections are a major issue in hospitals and age-care facilities. Biofilm formation in catheters can often result in encrustation and occlusion of the catheter, resulting in lack of urinary drainage and severe dissemination of infection. In my research, we investigated the novel effects of N-acetyl cysteine (NAC) on biofilm formation and matrix disruption using an in vitro glass bladder model. Furthermore, we also investigate the influence of NAC in host pathogen interactions, to elucidate how we can influence host cellular interactions to enhance biofilm removal.
Speaker: Professor Slade Jensen
Qualifications: B.Med.Sc. (USyd) PhD. (USyd). FASM
Speaker Profile:
Slade is a Professor of Microbiology and Infectious Diseases in the School of Medicine, Western Sydney University and Research Director of the Antibiotic Resistance and Mobile Elements Group, and the Limb Preservation and Wound Research Group, both of which are based at the Ingham Institute for Applied Medical Research. He obtained a Ph.D. from the University of Sydney focused on the role of horizontal gene transfer in bacterial evolution. His current research interests include the development of novel antimicrobials, the evolution of antibiotic resistance in hospital pathogens, such as ‘Golden Staph’, and the role of host-microbe interactions in disease progression, particularly in the context of diabetes-related foot ulcers.
Topic: Microbes, biofilms and diabetes-related foot ulcers
Presentation Outline: Slade will discuss how his team’s research has assisted in changing the understanding of the pathology of chronic ulceration in diabetic foot infections, from that of infection with planktonic bacteria to that of infection with biofilm. Due to the resistance of biofilms to antimicrobial penetration, increased emphasis is now given to removal of adequate volumes of tissue with debridement and the use of anti-biofilm compounds.
Speaker: Professor Kate Moore
Qualifications: MB BS Syd, MD Liv, FRCOG, FRANZCOG, CU
Speaker Profile:
Arthika is a Postdoctoral Research Fellow at the University of Sydney, having recently completed her PhD in collaboration with Whiteley Corporation, under the supervision of Dr. Theerthankar Das and A/Prof Jim Manos. Her research aims to tackle biofilm formation in recurrent and catheter associated urinary tract infections, using antioxidants to circumvent antibiotic resistance and decipher how these antioxidants influence host-pathogen interactions in the bladder. A microbiologist with extensive immunology experience, Arthika has worked in various projects ranging from studying CAR T cells to antibiotic resistant biofilms. With 6 publications under her belt, Arthika is an enthusiastic early career researcher interested in multidisciplinary research that combines fundamental and translational sciences. She is also an avid advocate for EMCRs in the medical sciences, having served extensively on various EMCR committees university wide and in professional bodies, including ASM.
Topic: Rethinking biofilm treatments in catheter associated urinary tract infections
Presentation Outline: Catheter-associated urinary tract infections are a major issue in hospitals and age-care facilities. Biofilm formation in catheters can often result in encrustation and occlusion of the catheter, resulting in lack of urinary drainage and severe dissemination of infection. In my research, we investigated the novel effects of N-acetyl cysteine (NAC) on biofilm formation and matrix disruption using an in vitro glass bladder model. Furthermore, we also investigate the influence of NAC in host pathogen interactions, to elucidate how we can influence host cellular interactions to enhance biofilm removal.
Speaker: Associate Professor Greg Whiteley
Qualifications: FEHA, MASM, MSHEA, PhD, M Safety Sc, B App, Dip AICD
Speaker Profile:
Dr Greg Whiteley is an Adjunct Associate Professor in the Faculty of Medicine and Health at the University of Sydney, a Fellow in the School of Medicine at Western Sydney University and is also the Executive Chairman of Whiteley Corporation. Assoc. Prof Whiteley’s qualifications include a Bachelor of Applied Science (Hawkesbury Agricultural College), a Master of Safety Science (University of New South Wales), a Diploma from the Australian Institute of Company Directors (University of New England) and a PhD (Western Sydney University).
Dr Whiteley is a Life Fellow of Environmental Health Australia, a Member of the Society of Healthcare Epidemiology of America and is a Member of the Australian Society of Microbiology. He currently serves as a director of the trade association known as ACCORD Australia, and also as an expert consultant to the Infection Control Committee for the Australian Dental Association. He has previously served on HE-023 with Standards Australia.
His on-going research interests focus on biofilms found within healthcare settings, healthcare hygiene and the cleanliness of medical devices. Findings from this research team include publications outlining the extent of biofilm problems within healthcare and other settings, monitoring solutions including ATP testing, and extensive findings on the cleaning and disinfecting implications from biofilms on healthcare surfaces and reusable medical devices.
Dr Whiteley has previously been an Industry Partner for an ARC Grant in conjunction with Macquarie University, a Collaboration Partner Study Director for an iMCRC Grant with the School of Medicine at Sydney University, the Study Director of a CRC-P Grant investigating novel diagnostic and treatment options for wound care co-jointly partnering with AMP Control and the University of Newcastle and Western Sydney University.
Dr Whiteley is currently the Executive Chairman of Whiteley Corporation. He bears ultimate responsibility under Commonwealth Legislation for the Therapeutic Goods registrations and the manufacturing license of the manufacturing location in Tomago. Dr Whiteley has additionally co-authored many patents and peer reviewed publications.
Topic: Advances in Biofilm TestingÂ
Presentation Outline: This topic will provide an overview into key lessons and research findings on dry surface and wet surface biofilms and their impact on critical healthcare departments. Published research on the presence of biofilms containing viable multi-resistant organisms and the critical role of rigorous cleaning processes to prevent hospital acquired infections (HAI’s). Understanding why cleaning protocols must adapt to account for our new logic of the role of biofilms in bacterial survival and transmission of infections.
Stay updated on special offers, new product updates, helpful information and more.
*Terms and conditions: 10% discount offer valid for first order only, over the value of $100.00.
Free shipping will also apply for orders over $99.00.